Cargando…

Magnetic resonance imaging features of breast cancer according to intrinsic subtypes: correlations with neoadjuvant chemotherapy effects

PURPOSE: The purpose of this study was to evaluate the magnetic resonance imaging (MRI) features of breast cancer according to intrinsic subtypes and to investigate whether the MRI and immunohistochemical findings were related to neoadjuvant chemotherapy (NAC) effects. MATERIALS AND METHODS: The MRI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kawashima, Hiroko, Inokuchi, Masafumi, Furukawa, Hiroyuki, Ikeda, Hiroko, Kitamura, Seiko
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4039660/ https://www.ncbi.nlm.nih.gov/pubmed/24892001 http://dx.doi.org/10.1186/2193-1801-3-240

Ejemplares similares

Response and survival of breast cancer intrinsic subtypes following multi-agent neoadjuvant chemotherapy
por: Prat, Aleix, et al.
Publicado: (2015)

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

Breast cancer subtyping by immunohistochemistry and histological grade outperforms breast cancer intrinsic subtypes in predicting neoadjuvant chemotherapy response
por: Lips, E. H., et al.
Publicado: (2013)

Intrinsic subtype distribution should vary according to institutions
por: Horimoto, Yoshiya, et al.
Publicado: (2020)

The Benefit of Post-Mastectomy Radiotherapy in ypN0 Patients after Neoadjuvant Chemotherapy According to Molecular Subtypes
por: Cho, Won Kyung, et al.
Publicado: (2019)

Response to: Intrinsic subtype distribution should vary according to institutions
por: Fischer Maranta, Angela, et al.
Publicado: (2020)

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype
por: Fukuda, Takayo, et al.
Publicado: (2016)

Prognostic Significance of a Complete Response on Breast MRI in Patients Who Received Neoadjuvant Chemotherapy According to the Molecular Subtype
por: Ko, Eun Sook, et al.
Publicado: (2015)

The Value of Tumor Infiltrating Lymphocytes (TIL) for Predicting the Response to Neoadjuvant Chemotherapy (NAC) in Breast Cancer according to the Molecular Subtypes
por: Faur, Ionut Flaviu, et al.
Publicado: (2023)

Preoperative Breast Magnetic Resonance Imaging as a Predictor of Response to Neoadjuvant Chemotherapy
por: Browne, Robert, et al.
Publicado: (2022)

Molecular hallmarks of breast multiparametric magnetic resonance imaging during neoadjuvant chemotherapy
por: Lin, Peng, et al.
Publicado: (2023)

The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy
por: Straver, M. E., et al.
Publicado: (2010)

A phase I study of neoadjuvant chemotherapy with gemcitabine plus oral S-1 for resectable pancreatic cancer
por: TAJIMA, HIDEHIRO, et al.
Publicado: (2013)

Strong impact of pathological node-negative on long-term overall survival of patients with triple-negative breast cancer receiving neoadjuvant chemotherapy
por: Nogi, Hiroko, et al.
Publicado: (2021)

Meta-analysis of nanoparticle albumin-bound paclitaxel used as neoadjuvant chemotherapy for operable breast cancer based on individual patient data (JBCRG-S01 study)
por: Futamura, Manabu, et al.
Publicado: (2021)

Inflammatory Myofibroblastic Tumor of the Urinary Bladder with Benign Pelvic Lymph Node Enlargement: A Case Report
por: Machioka, Kazuaki, et al.
Publicado: (2014)

Role of Diffusion-Weighted Magnetic Resonance Imaging in Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer and Its Molecular Subtypes
por: Singh, Neetu, et al.
Publicado: (2022)

Protein and lipid MALDI profiles classify breast cancers according to the intrinsic subtype
por: Kang, Han Sung, et al.
Publicado: (2011)

Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combination
por: Swain, Sandra M., et al.
Publicado: (2019)

The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
por: Araki, Yoshihiro, et al.
Publicado: (2021)

Neoadjuvant chemotherapy for epithelial ovarian cancer in Japan: a JSGO-JSOG joint study
por: Machida, Hiroko, et al.
Publicado: (2019)

Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage
por: De Robertis, Riccardo, et al.
Publicado: (2017)

An evaluation of lymphovascular invasion in relation to biology and prognosis according to subtypes in invasive breast cancer
por: Nishimura, Reiki, et al.
Publicado: (2022)

Sigmoid model analysis of breast dynamic contrast‐enhanced MRI: Distinguishing between benign and malignant breast masses and breast cancer subtype prediction
por: Koori, Norikazu, et al.
Publicado: (2022)

Ultrasonographic Features of Papillary Thyroid Carcinomas According to Their Subtypes
por: Baek, Hye Jin, et al.
Publicado: (2018)

Pattern of recurrence of early breast cancer is different according to intrinsic subtype and proliferation index
por: Ribelles, Nuria, et al.
Publicado: (2013)

Author Correction: The number of osteoclasts in a biopsy specimen can predict the efficacy of neoadjuvant chemotherapy for primary osteosarcoma
por: Araki, Yoshihiro, et al.
Publicado: (2021)

Current and Future Trends in Magnetic Resonance Imaging Assessments of the Response of Breast Tumors to Neoadjuvant Chemotherapy
por: Arlinghaus, Lori R., et al.
Publicado: (2010)

Magnetic Resonance Imaging Evaluation of Noninflammatory Breast Cancer with Skin Involvement After Neoadjuvant Chemotherapy
por: Chen, Jeon-Hor, et al.
Publicado: (2010)

Clinical Application of Magnetic Resonance Imaging in Management of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy
por: Chen, Jeon-Hor, et al.
Publicado: (2013)

Machine learning with multiparametric magnetic resonance imaging of the breast for early prediction of response to neoadjuvant chemotherapy
por: Lo Gullo, Roberto, et al.
Publicado: (2019)

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk
por: Magbanua, Mark Jesus M., et al.
Publicado: (2021)

Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy
por: Hamy, Anne-Sophie, et al.
Publicado: (2020)

Assessment of axillary node status by ultrasound after neoadjuvant chemotherapy in patients with clinically node-positive breast cancer according to breast cancer subtype
por: Maeshima, Yurina, et al.
Publicado: (2021)

Magnetic resonance radiomics features and prognosticators in different molecular subtypes of pediatric Medulloblastoma
por: Chang, Feng-Chi, et al.
Publicado: (2021)

Editorial: Recent advancements in neoadjuvant chemotherapy for specific breast cancer subtypes
por: Adham, Sirin A., et al.
Publicado: (2022)

EARLY PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER USING MRI
por: KAWAMURA, MARIKO, et al.
Publicado: (2011)

Subtype of SCLC Is an Intrinsic and Persistent Feature Through Systemic Treatment
por: Lo, Ying-Chun, et al.
Publicado: (2023)

Predicting Complete Response to Neoadjuvant Chemotherapy in Muscle-Invasive Bladder Cancer
por: Miyagi, Hiroko, et al.
Publicado: (2022)

Local-regional control according to surrogate markers of breast cancer subtypes and response to neoadjuvant chemotherapy in breast cancer patients undergoing breast conserving therapy
por: Caudle, Abigail S, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_6mree9606p4take0tjdrhuq6fo